About us
Strategic Planning
“Never invest in any idea you can't illustrate with
a crayon”
Peter Lynch
The pursuit of a small life sciences company's strategic objectives is inherently fraught with uncertainty. Such uncertainty equates directly with risk, and can be further compounded by the vagaries of the life sciences market and the constantly changing inclinations of the investors. Consequently many smaller companies often struggle to communicate effectively with investors; attract finance and ultimately to execute their strategic plan, to full effect.
Elixir’s investment banking practice is not therefore an execution-only business. We operate as ‘enablers’, listening to the market; helping our clients to position and shape their businesses to become more attractive to investors or strategic acquirers; and communicating often complex concepts to investors, on a level which is commensurate with their understanding. We aim to develop long term solutions, irrespective of the challenges that the market environment may present, because they are right for stakeholders; not because they are easiest for us as an advisor.
Elixir helps smaller companies to identify and develop
their key strategic messages and to prepare professional prospectuses
(for product licensing purposes); private placement memorandums and marketing
presentations.
Elixir has worked on a number of product licensing
mandates for companies seeking to find strategic partners for products,
both in Europe and outside.
Elixir is also able to provide advisory
services relating to mergers and acquisitions, including the identification
and analysis of strategic acquisition targets.
Pre-Due Diligence ("PreD") Reports
The current economic conditions have added to already challenging times in the UK life sciences sectors. The scarcity of early stage capital which is available for investment, is well recognised. However, at a time when more companies than ever are looking for transactions, we are also seeing a contraction in the number of specialist investors, advisors and infrastructure. PreD reports are intended to fill this growing gap in expertise for the benefit of Corporates, Advisors and Investors.
Read More About PreD Reports »
If you would like to talk to Elixir about a specific project, please click on the button below. The most appropriate person will then contact you directly, to discuss your specific needs.
